InsiderTrades

Form 4 for AORT ARTIVION, INC.

Accepted 2026-03-04 00:00:00 ET · period of report 2026-03-02 · accession 0001628280-26-014887 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
2026-03-04 2026-03-02 AORT Mackin James P Pres, CEO A - Grant $0.00 +116.9K 965.2K +14% $0
2026-03-04 2026-03-03 AORT Mackin James P Pres, CEO S - Sale $37.78 -17.9K 947.3K -2% -$675.8K

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-03-02 A A 116,948 $0.00 965,162 D — — (F1) Represents performance stock units granted on February 28, 2025. One third (1/3) were issued on March 2, 2026. The remaining shares earned in connection with the February 2025 grant will be eligible to vest and be issued as follows: one third (1/3) on February 28, 2027; and one third (1/3) on February 28, 2028, assuming employment on the relevant vesting date.
2 Common Common Stock 2026-03-03 S D 17,887 $37.78 947,275 D — — (F2) These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.